Literature DB >> 5807978

Lactic acid dehydrogenase activity and plasma hemoglobin elevations in sickle cell disease.

C L Neely, T Wajima, A P Kraus, L W Diggs, L Barreras.   

Abstract

Mesh:

Substances:

Year:  1969        PMID: 5807978     DOI: 10.1093/ajcp/52.2.167

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


× No keyword cloud information.
  15 in total

1.  Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality.

Authors:  Gregory J Kato; Sabrina Martyr; William C Blackwelder; James S Nichols; Wynona A Coles; Lori A Hunter; Marie-Luise Brennan; Stanley L Hazen; Mark T Gladwin
Journal:  Br J Haematol       Date:  2005-09       Impact factor: 6.998

2.  Cerebrovascular disease associated with sickle cell pulmonary hypertension.

Authors:  Gregory J Kato; Matthew Hsieh; Roberto Machado; James Taylor; Jane Little; John A Butman; Tanya Lehky; John Tisdale; Mark T Gladwin
Journal:  Am J Hematol       Date:  2006-07       Impact factor: 10.047

3.  Lactate dehydrogenase and hemolysis in sickle cell disease.

Authors:  Gregory J Kato; Seyed Mehdi Nouraie; Mark T Gladwin
Journal:  Blood       Date:  2013-08-08       Impact factor: 22.113

4.  Monitoring the acute phase response to vaso-occlusive crisis in sickle cell disease.

Authors:  J Stuart; P C Stone; N O Akinola; J R Gallimore; M B Pepys
Journal:  J Clin Pathol       Date:  1994-02       Impact factor: 3.411

5.  Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease.

Authors:  Gregory J Kato; Vicki McGowan; Roberto F Machado; Jane A Little; James Taylor; Claudia R Morris; James S Nichols; Xunde Wang; Mirjana Poljakovic; Sidney M Morris; Mark T Gladwin
Journal:  Blood       Date:  2005-11-15       Impact factor: 22.113

6.  Variation in serum electrolytes and enzyme concentrations in patients with sickle cell disease.

Authors:  N Nduka; Y Kazem; B Saleh
Journal:  J Clin Pathol       Date:  1995-07       Impact factor: 3.411

7.  Apolipoprotein A-I and serum amyloid A plasma levels are biomarkers of acute painful episodes in patients with sickle cell disease.

Authors:  Ashaunta Tumblin; Anitaben Tailor; Gerard T Hoehn; A Kyle Mack; Laurel Mendelsohn; Lita Freeman; Xiuli Xu; Alan T Remaley; Peter J Munson; Anthony F Suffredini; Gregory J Kato
Journal:  Haematologica       Date:  2010-04-07       Impact factor: 9.941

8.  Activation of the alternative pathway of human complement by haemoglobin.

Authors:  W A Wilson; E J Thomas
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330

9.  Subclinical ischaemic episodes during the steady state of sickle cell anaemia.

Authors:  N O Akinola; S M Stevens; I M Franklin; G B Nash; J Stuart
Journal:  J Clin Pathol       Date:  1992-10       Impact factor: 3.411

Review 10.  Pulmonary hypertension in sickle cell disease: relevance to children.

Authors:  Gregory J Kato; Onyinye C Onyekwere; Mark T Gladwin
Journal:  Pediatr Hematol Oncol       Date:  2007 Apr-May       Impact factor: 1.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.